touchIN CONVERSATION for touchENDOCRINOLOGY

Listen to Dr Nadia Merchant in conversation with Dr Andrew Dauber. They respond to questions submitted by the HCP audience and provide their expert insights on the physiology of normal and abnormal bone growth, and the assessment and treatment of children with achondroplasia.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from BioMarin. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/in-conversation-paediatric-growth-patterns-and-their-impact-on-health-in-achondroplasia 

touchTALKS for touchRESPIRATORY

Listen to an esteemed lung cancer expert discuss KRAS mutations in solid tumours, particularly non-small cell lung cancer and colorectal cancer, and consider the role of direct KRAS-G12C inhibitors in targeting these mutations and potential strategies to overcome resistance.

The expert:

• Prof. Tony Mok, Chinese University of Hong Kong, Hong Kong

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Novartis. This activity is provided by touchIME.

For further information visit our website: https://www.touchrespiratory.com/education/kras-g12c-inhibitors-for-solid-tumours/

touchCONGRESS for touchONCOLOGY

Listen to Professor Giuseppe Saglio (Italy) cover key data presented at the EHA Hybrid Conference 2022 on the efficacy and safety of current and emerging treatments for CML, and how these may influence clinical practice, as well as expert insights and interpretation from Professor François-Xavier Mahon (France) and Professor Dietger Niederwieser (Germany).

Overview

• Data review with Professor Giuseppe Saglio (00:54)

Interview questions

• When considering the new 96-week data for asciminib from the ASCEMBL trial, how do you think these results will impact clinical practice? (35:00)

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Novartis Pharmaceuticals. This activity is provided by touchIME.

For further information visit our website: www.touchoncology.com

touchIN CONVERSATION for touchONCOLOGY

Listen to gynaecologic oncology specialists Prof. Nicoletta Colombo and Dr Natalia R Gómez-Hidalgo discuss three key topics relating to PARP inhibitors in the first-line maintenance setting for advanced ovarian cancer – rationale for use, which patients may particularly benefit, and key factors informing PARP inhibitor selection.

Discussion on these themes is based on questions posed by healthcare professionals involved in the care of patients with ovarian cancer.

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME.

For further information visit our website: 

https://touchoncology.com/education/parp-inhibitors-maintenance-inconvo2022/

touchPANEL DISCUSSION for touchIMMUNOLOGY

Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE.

The experts

Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA

Dr Sharon Hall - Imperial College Healthcare NHS Trust, London, UK

Dr Salvatore Oliva - Sapienza University of Rome, Rome, Italy

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information please visit our website: https://touchimmunologyime.org/

touchPANEL DISCUSSION for touchRESPIRATORY 

Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE.

The experts

Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA

Dr Sharon Hall - Imperial College Healthcare NHS Trust, London, UK

Dr Salvatore Oliva - Sapienza University of Rome, Rome, Italy

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information please visit our website: https://touchrespiratoryime.org/

touchPANEL DISCUSSION for touchNEUROLOGY

Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing. 

The experts

• Prof. Gavin Giovannoni (Chair), Blizard Institute, Queen Mary University of London, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/ 

touchPANEL DISCUSSION for touchONCOLOGY

Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer.

The experts

• Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/high-risk-hrpositive-her2negative-early-breast-cancer-risk-stratification-and-treatment-strategies/

touchIN CONVERSATION for touchONCOLOGY

Listen to Dr Randy Broun, a community oncologist and haematologist, in conversation with Dr Faith Davies, a multiple myeloma expert. They respond to questions submitted by the HCP audience and provide their expert insights on how real-world evidence can guide the management of elderly and frail patients with multiple myeloma.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Takeda Pharmaceuticals USA Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchoncology.com

touchPANEL DISCUSSION for touchONCOLOGY

Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan.

The experts

• Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent grant from the healthcare business of Merck KGaA, Darmstadt. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchoncology.com/cme/treatment-provision-recurrent-metastatic-hnscc/